Home › Kanser (lahat ng uri) › Michigan › Ann Arbor
Pag-aaral pangklinika para sa Kanser (lahat ng uri) sa Ann Arbor, MI
Isang pag-aaral para sa Kanser (lahat ng uri) ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Ann Arbor. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study of ASP3082 in Adults With Advanced Solid Tumors
Nagre-recruitPhase 1
- Trinity Health Ann Arbor Hospital, Ypsilanti · 7 mi ang layo
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Nagre-recruitObservasyonal na pag-aaral
- University of Michigan, Ann Arbor
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
Nagre-recruitPhase 1
- University of Michigan, Ann Arbor
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Nagre-recruitPhase 3
- University of Michigan Health System, Ann Arbor
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Nagre-recruitPhase 3
- Quetzal Site 22, Ann Arbor
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Nagre-recruitPhase 2
- Trinity Health Ann Arbor Hospital, Ann Arbor
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Nagre-recruitPhase 2/3
- University Of Michigan Comprehensive Cancer Center, Ann Arbor
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Nagre-recruitPhase 2
- University of Michigan, Ann Arbor
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
Nagre-recruitPhase 1/2
- University of Michigan Health System - Ann Arbor /ID# 271536, Ann Arbor
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Nagre-recruitPhase 1
- University of Michigan, Ann Arbor
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Nagre-recruitPhase 3
- University of Michigan, Ann Arbor
Prostate Active Surveillance Study
Nagre-recruitObservasyonal na pag-aaral
- University of Michigan, Ann Arbor
Lurbinectedin in FET-Fused Tumors
Nagre-recruitPhase 1/2
- University of Michigan, Ann Arbor
Project: Every Child for Younger Patients With Cancer
Nagre-recruitObservasyonal na pag-aaral
- C S Mott Children's Hospital, Ann Arbor
Abatacept in Immune Checkpoint Inhibitor Myocarditis
Nagre-recruitPhase 3
- University of Michigan, Ann Arbor
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Nagre-recruitPhase 2
- C.S. Mott Children's Hospital, Ann Arbor
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Nagre-recruitPhase 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7 mi ang layo
- at 6 pa
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Nagre-recruitPhase 2
- University of Michigan Health System - Ann Arbor /ID# 273511, Ann Arbor
Childhood Cancer Survivor Study
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- University of Michigan/Mott Children's Hospital, Ann Arbor
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Nagre-recruit
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Nagre-recruitPhase 1
- University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 252010, Ann Arbor
Suprachoroidal Administration in Subjects With Metastases to the Choroid
Nagre-recruitPhase 2
- Kellogg Eye Center, Ann Arbor
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Nagre-recruit
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Ann Arbor
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Nagre-recruit
- University of Michigan Medical Center, Ann Arbor
- University of Michigan - Brighton Center for Specialty Care, Brighton · 18 mi ang layo
Pag-aaral para sa Kanser (lahat ng uri) sa ibang lungsod
- Houston, TX121 pag-aaral
- New York City, NY109 pag-aaral
- Boston, MA85 pag-aaral
- Los Angeles, CA74 pag-aaral
- Nashville, TN65 pag-aaral
- Philadelphia, PA59 pag-aaral
- Washington, DC58 pag-aaral
- Durham, NC58 pag-aaral
- Chicago, IL51 pag-aaral
- Atlanta, GA49 pag-aaral
- Seattle, WA49 pag-aaral
- Arlington, VA48 pag-aaral
Iba pang pag-aaral sa Ann Arbor
- Kanser sa Suso27 pag-aaral
- Kanser sa Prostate27 pag-aaral
- Non-Small Cell Lung Cancer26 pag-aaral
- Kanser sa Baga23 pag-aaral
- Colorectal Cancer23 pag-aaral
- Pagkabigo ng Puso22 pag-aaral
- Acute Myeloid Leukemia17 pag-aaral
- Sakit sa Puso at Ugat ng Dugo16 pag-aaral
- Kanser sa Pancreas14 pag-aaral
- Melanoma12 pag-aaral
- Stroke12 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg12 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.